James Helliwell
Vermögen: 7 Mio $ am 31.07.2026
Vermögen: 7 Mio $ am 31.07.2026
James A. Helliwell is the founder of Eupraxia Pharmaceuticals, Inc., founded in 2011, where Dr. Helliwell holds the titles of Chief Executive Officer & Director.
Dr. Helliwell is also the founder of Accuro Technologies, Inc...
Dr. Helliwell is currently the Chairman at Guidestar Medical Devices.
Formerly, Dr. Helliwell was an Assistant Professor at the University of British Columbia.
Dr. Helliwell completed undergraduate education at the University of British Columbia.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 1 055 012 ( 1,61 % ) | 7 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Gründer | 12.05.2011 |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Vorsitzender | - |
Accuro Technologies, Inc. | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Technologies, Inc. | |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen